For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is associated with improved clinical outcomes.

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Background The River stent is the first stent specifically designed for intracranial venous sinuses. We report the 1-year results of the River trial, performed to obtain Humanitarian Device Exemption ...

Diagnostic markers are biological parameters that aid the diagnosis of diseases. Examples include the presence of particular genetic variants and the levels of particular proteins in body fluids ...

We report a rare case of a female patient in her early 50s who presented with unilateral transient visual symptoms that resolved shortly. On examination, the anterior segment exam was unremarkable ...